Pharma major AstraZeneca and University of Oxford are working on modifying their existing Covid-19 vaccine — called Covishield in India — to become effective against the South African coronavirus variant.
Says who?
What about India?
Pharma major AstraZeneca and University of Oxford are working on modifying their existing Covid-19 vaccine — called Covishield in India — to become effective against the South African coronavirus variant.
Says who?
What about India?